Literature DB >> 9758906

HLA-E is the ligand for the natural killer cell CD94/NKG2 receptors.

P E Posch1, F Borrego, A G Brooks, J E Coligan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9758906     DOI: 10.1007/bf02253442

Source DB:  PubMed          Journal:  J Biomed Sci        ISSN: 1021-7770            Impact factor:   8.410


× No keyword cloud information.
  7 in total

1.  NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes.

Authors:  Robert J Freishtat; Lindsay W Mitchell; Svetlana D Ghimbovschi; Samuel B Meyers; Eric P Hoffman
Journal:  Hum Immunol       Date:  2006-03-27       Impact factor: 2.850

2.  NKG2A is a marker for acquisition of regulatory function by human CD8+ T cells activated with anti-CD3 antibody.

Authors:  Vitaly Ablamunits; Octavian Henegariu; Paula Preston-Hurlburt; Kevan C Herold
Journal:  Eur J Immunol       Date:  2011-06-06       Impact factor: 5.532

Review 3.  The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.

Authors:  Gabriella Pietra; Chiara Romagnani; Claudia Manzini; Lorenzo Moretta; Maria Cristina Mingari
Journal:  J Biomed Biotechnol       Date:  2010-06-22

Review 4.  Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies.

Authors:  Chuang Sun; Gianpietro Dotti; Barbara Savoldo
Journal:  Blood       Date:  2016-05-20       Impact factor: 22.113

5.  Natural killer cells in healthy and diseased subjects.

Authors:  Roberto Biassoni; John E Coligan; Lorenzo Moretta
Journal:  J Biomed Biotechnol       Date:  2011-08-29

Review 6.  HLA-E: a novel player for histocompatibility.

Authors:  Thomas Kraemer; Rainer Blasczyk; Christina Bade-Doeding
Journal:  J Immunol Res       Date:  2014-10-20       Impact factor: 4.818

7.  NKG2A inhibits TH2 cell effector function in vitro.

Authors:  Robert J Freishtat; Bahar Mojgani; Maryam Nazemzadeh; Kanneboyina Nagaraju; Eric P Hoffman
Journal:  BMC Pulm Med       Date:  2007-10-10       Impact factor: 3.317

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.